UNICA IRIS Institutional Research Information System

DEFAZIO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 172.965
NA - Nord America 13.967
AS - Asia 5.340
SA - Sud America 1.751
AF - Africa 133
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 3
Totale 194.181
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 170.246
US - Stati Uniti d'America 13.674
SG - Singapore 2.332
CN - Cina 1.646
BR - Brasile 1.425
SE - Svezia 648
VN - Vietnam 623
UA - Ucraina 408
DE - Germania 388
GB - Regno Unito 308
FI - Finlandia 248
CA - Canada 179
FR - Francia 163
AR - Argentina 144
NL - Olanda 136
IN - India 106
TR - Turchia 99
KR - Corea 90
MX - Messico 68
AT - Austria 67
EC - Ecuador 60
JP - Giappone 59
ID - Indonesia 57
RU - Federazione Russa 56
HK - Hong Kong 54
BD - Bangladesh 45
ES - Italia 42
ZA - Sudafrica 42
PL - Polonia 35
CO - Colombia 32
IQ - Iraq 32
CH - Svizzera 29
IR - Iran 26
RO - Romania 26
IE - Irlanda 23
EG - Egitto 22
MA - Marocco 22
PY - Paraguay 21
CL - Cile 20
AE - Emirati Arabi Uniti 19
BE - Belgio 19
CZ - Repubblica Ceca 18
SA - Arabia Saudita 18
AL - Albania 17
VE - Venezuela 17
PE - Perù 16
IL - Israele 15
PK - Pakistan 15
TW - Taiwan 15
UZ - Uzbekistan 14
GR - Grecia 13
PH - Filippine 13
AU - Australia 11
NZ - Nuova Zelanda 11
DO - Repubblica Dominicana 10
KE - Kenya 10
MY - Malesia 10
PT - Portogallo 10
JM - Giamaica 9
BG - Bulgaria 8
RS - Serbia 8
UY - Uruguay 8
AZ - Azerbaigian 7
HU - Ungheria 7
JO - Giordania 7
NG - Nigeria 7
NP - Nepal 7
BO - Bolivia 6
CR - Costa Rica 6
DZ - Algeria 6
GH - Ghana 6
KZ - Kazakistan 6
LT - Lituania 6
MG - Madagascar 5
TN - Tunisia 5
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
EE - Estonia 4
HR - Croazia 4
KG - Kirghizistan 4
LV - Lettonia 4
OM - Oman 4
PA - Panama 4
TH - Thailandia 4
BB - Barbados 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
GT - Guatemala 3
HN - Honduras 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
BZ - Belize 2
ET - Etiopia 2
IS - Islanda 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
MK - Macedonia 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
Totale 194.161
Salva come PNG Salva come JPEG
Città #
Cagliari 160.206
Uta 5.701
Fairfield 2.306
Ashburn 1.339
Woodbridge 982
Seattle 894
Singapore 821
Houston 812
Boardman 810
Wilmington 753
Dallas 746
Cambridge 740
Nyköping 496
Ann Arbor 444
Beijing 410
Milan 370
Rome 366
Chandler 321
Helsinki 224
Boston 216
Los Angeles 213
Jacksonville 209
Ho Chi Minh City 204
Shanghai 200
New York 192
Nanjing 164
Buffalo 145
Guangzhou 137
São Paulo 134
Hanoi 133
Santa Clara 133
Munich 125
San Diego 121
The Dalles 114
Dearborn 111
Toronto 107
Naples 99
Redwood City 79
Turin 79
London 76
Bologna 69
Catania 69
Florence 64
Millbury 63
Norwalk 57
Dong Ket 56
Shenyang 56
Trabzon 56
Bari 54
Seoul 53
Augusta 52
Changsha 50
Hefei 50
Nuremberg 48
Tianjin 46
Chicago 45
Verona 43
Hong Kong 41
Rio de Janeiro 41
Jiaxing 40
Palermo 40
Hebei 39
Redondo Beach 38
Nanchang 36
Frankfurt am Main 35
Tokyo 33
Vienna 33
Padova 32
Curitiba 31
San Mateo 31
Genoa 30
Brasília 28
Belo Horizonte 27
Mountain View 26
Atlanta 24
Guayaquil 24
Haiphong 24
Sassari 24
Düsseldorf 23
Parma 23
Wuhan 23
Pescara 22
Montreal 21
Orange 21
Brooklyn 20
Chennai 20
Da Nang 20
Denver 20
Perugia 20
Phoenix 20
Salvador 20
Brescia 19
Fortaleza 19
Thái Bình 19
Stockholm 18
Messina 17
Moscow 17
Syracuse 17
Biên Hòa 16
Buenos Aires 16
Totale 183.771
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of the 5-Hydroxytryptophan on Levodopa-Induced Motor Complications in Parkinson's disease 24.315
Effect of olfactory and gustatory dysfunction and motor symptoms on body weight in patients with Parkinson’s disease 4.424
Neurosifilide e stroke ischemico: case report. 3.569
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Parkinson's disease: a preliminary finding 3.294
Olfactory function and apathy as potential biomarker in patients with Parkinson's disease 2.998
Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial 2.714
Gender differences in olfactory function in patients with Parkinson's disease. 2.440
Epilessia mioclonica progressiva o epilessia parziale continua? 2.410
Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson's disease 2.350
Correlation among olfactory function, motors’ symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson’s disease 2.299
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.296
Efficacy and Safety of the 5-Hydroxytryptophan on REM Sleep Behavior Disorder in Parkinson's Disease 2.228
Sleep cardiac dysautonomia and EEG oscillations in Amyotrophic Lateral Sclerosis 2.220
Severity of REM sleep without atonia (RSWA) correlates with cognitive functions in patients with REM sleep behaviour disorder (RBD) 2.156
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Idiopathic Parkinson's disease 2.125
Neuropsychological and behavioral profile of patients with isolated REM sleep behaviour disorders (iRBD) and patients with RBD associated with Parkinson's Disease (PDRBD) 2.094
Gender differences in olfactory dysfunctions in Sardinian patients affected by Parkinson’s disease 2.079
CORRELATION AMONG OLFACTORY DYSFUNCTION, APATHY AND FATIGUE IN PATIENTS WITH PARKINSON’S DISEASE 2.051
Upper limb movements in dementia with Lewy body: a quantitative analysis 1.948
Sensory trick in upper limb dystonia 1.939
Pulvinar sign in a case of anti-CV2 encephalitis 1.878
A “Catastrophic” Heparin-Induced Thrombocytopenia 1.857
Association between dopaminergic medications and REM sleep behavior disorder in Parkinson’s disease: a preliminary cohort study 1.731
NCSE: un caso di steroid-responsive encephalopathy associated with autoimmune thyroiditis 1.672
Genetic Creutzfeldt-Jakob disease in Sardinia: a case series linked to the PRNP R208H mutation due to a single founder effect 1.636
Prevalence of Huntington's disease in Southern Sardinia, Italy 1.599
Geographic differences in the incidence of Huntington's disease in Sardinia, Italy 1.554
Internal carotid artery dissection causing ischemic stroke during pole sport practice 1.537
Impact of supporting people with advanced Parkinson’s disease on carer’s quality of life and burden 1.535
Expert recommendations for diagnosing cervical, oromandibular, and limb dystonia 1.532
Carotid plaque imaging profiling in subjects with risk factors (diabetes and hypertension) 1.489
Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study 1.407
The Relationships Between Ataxia and Cognition in Spinocerebellar Ataxia Type 2 1.386
Does acute peripheral trauma contribute to idiopathic adult-onset dystonia? 1.282
Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia 1.257
Does the network model fits neurophysiological abnormalities in blepharospasm? 1.203
Cerebellar Syndrome Associated with Thyroid Disorders 1.200
Serum anti-thyroid antibodies in Hashimoto’s encephalopathy: A never-ending story 1.198
Idiopathic Non-Task-Specific Upper Limb Dystonia, a Neglected Form of Dystonia 1.149
Demographic and clinical determinants of neck pain in idiopathic cervical dystonia 1.143
Cannabinoids and dystonia: an issue yet to be defined 1.140
Advances in the pathophysiology of adult-onset focal dystonias: recent neurophysiological and neuroimaging evidence. 1.117
Movement disorders phenomenology in focal motor seizures 1.061
Functional neurological disorder after COVID-19 vaccination 1.060
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 1.033
Cognitive and Behavioral features of isolated Rem Sleep Bhaviour disorders (IRBD) and RBD associated with Parkinson's disease (PDRBD 1.019
Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest? 978
The role of sensory information in the pathophysiology of focal dystonias 943
Status epilepticus in Hashimoto's encephalopathy 938
Neurophysiological features of REM sleep Behaviour Disorder (RBD) correlate with cognitive and psycho-behavioral profile 933
Role of dopaminergic neurotransmission in pathophysiology of action tremor in Parkinson's disease 928
Effects of White Matter Hyperintensities on Brain Connectivity and Hippocampal Volume in Healthy Subjects According to Their Localization 912
Therapeutic Use of Cerebellar Intermittent Theta Burst Stimulation (iTBS) in a Sardinian Family Affected by Spinocerebellar Ataxia 38 (SCA 38) 909
Qualitative smell/taste disorders as sequelae of acute COVID-19 862
Diagnostic criteria for blepharospasm: A multicenter international study 856
Disease progression in blepharospasm: a 5-year longitudinal study 842
Development of a Clinical Rating Scale for the Severity of Apraxia of Eyelid Opening, Either Isolated or Associated with Blepharospasm 842
Persistent myoclonic jerks: a case of epilepsia partialis continua or myoclonic progressive epilepsy? 841
Reshaping cortical connectivity in traumatic spinal cord injury: a novel effect of hyperbaric oxygen therapy 839
Risk factors of Parkinson disease. Simultaneous assessment, interactions, and etiologic subtypes 833
Frequency and Determinants of Olfactory Hallucinations in Parkinson’s Disease Patients 827
Effetti della stimolazione del nervo vago sulle componenti aperiodiche dell’EEG in soggetti affetti da epilessia resistente ai farmaci 823
Olfactory impairment in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype: a pilot study 802
Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease 787
Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease 781
Is Adult-Onset Dystonia a Rare Disease? Time for Population-Based Studies 757
Does Olfactory Dysfunction Correlate with Disease Progression in Parkinson’s Disease? A Systematic Review of the Current Literature 750
Pain in Parkinson's disease: facts and uncertainties 736
Neuroimaging in idiopathic adult-onset focal dystonia 710
Rasagiline withdrawal Syndrome in Parkinson’s Disease 693
23. Effects of vagal nerve stimulation on EEG aperiodic parameters in subjects affected by drug-resistant epilepsy 692
Validation of a guideline to reduce variability in diagnosing cervical dystonia 690
Olfactory Impairment Correlates with Executive Functions Disorders and Other Specific Cognitive Dysfunctions in Parkinson’s Disease 684
Incidence of amyotrophic lateral sclerosis in Sardinia, Italy: age-sex interaction and spatial-temporal variability 673
Pain in focal dystonias - A focused review to address an important component of the disease 670
Whole-exome sequencing for variant discovery in blepharospasm 661
The Pathophysiological Correlates of Parkinson's Disease Clinical Subtypes 661
Global Fractional Anisotropy: Effect on Resting-state Neural Activity and Brain Networking in Healthy Participants 656
Early juvenile reading epilepsy and later frontotemporal dementia (FTD): expanding the clinical phenotype of C9ORF72 mutation? 652
Neurological phenomenology of the IRF2BPL mutation syndrome: Analysis of a new case and systematic review of the literature 633
Functional gait disorders: Demographic and clinical correlations 629
The mid-term effects of carotid endarterectomy on cognition and regional neural activity analyzed with the amplitude of low frequency fluctuations technique 622
Estimated EEG functional connectivity and aperiodic component induced by vagal nerve stimulation in patients with drug-resistant epilepsy 611
Motor and non-motor symptoms in blepharospasm: clinical and pathophysiological implications 608
Incidence and spatial distribution of adult-onset primary malignant and other central nervous system tumors in Southern Sardinia, Italy 603
Olfactory hallucinations in Parkinson’s disease patients and the role of their evaluation in clinical practice. 601
Functional neurological disorders as seen by a cohort of general practitioners in northern italy: Evidence from an online survey 599
Association between olfactory dysfunction and motor subtypes in Parkinson’s disease: are non‑tremor‑dominant subtypes really uncorrelated to olfactory impairment? 598
Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site 563
A neural network-based software to recognise blepharospasm symptoms and to measure eye closure time 559
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson's disease 553
Effect of botulinum toxin on non-motor symptoms in cervical dystonia 550
The Italian Dystonia Registry: rationale, design and preliminary findings 543
Cocaine-induced Pisa syndrome 540
Blepharospasm 40 years later 535
Severity of REM sleep without atonia correlates with measures of cognitive impairment and depressive symptoms in REM sleep behaviour disorder 533
Smoking and age-at-onset of both motor and non-motor symptoms in Parkinson's disease 531
Involuntary Thumb Flexion on Neurological Examination: An Unusual Form of Upper Limb Dystonia in the Faroe Islands 526
The association between white matter hyperintensities, cognition and regional neural activity in healthy subjects 518
Does epilepsy contribute to the clinical phenotype of C9orf72 mutation in fronto-temporal dementia? 510
Totale 145.750
Salva come PNG Salva come JPEG
Categoria #
all - tutte 299.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 299.938
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117.657 0 0 0 0 0 4.812 2.784 2.738 1.134 2.441 2.348 1.400
2021/202212.330 1.238 1.000 644 773 987 875 983 744 940 1.152 1.389 1.605
2022/202319.596 1.827 2.335 2.144 1.487 1.453 1.613 1.089 2.658 1.171 1.325 1.535 959
2023/202425.018 1.230 906 1.098 2.041 2.370 3.627 4.003 1.727 1.174 1.800 2.619 2.423
2024/202563.650 16.422 11.979 13.964 7.540 3.018 3.629 4.114 268 840 912 403 561
2025/20266.386 1.149 434 1.871 1.923 915 94 0 0 0 0 0 0
Totale 195.291